Paclitaxel-induced neutrophilic adverse reaction and acral erythema

Acta Dermato-Venereologica

Volumn 91, Issue 1, 2011, Pages 86-87

  Cruz, Antonio ^a   Temu, Tecla ^b   Hines Telang, Gladys ^a   Kroumpouzos, George ^a  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; CLOBETASOL; DIPHENHYDRAMINE; LEVOTHYROXINE; PACLITAXEL; RANITIDINE; VITAMIN D;

ACANTHOSIS; ACRAL ERYTHEMA; AGED; BREAST CANCER; CASE REPORT; CELL DEATH; CELL INFILTRATION; DYSKERATOSIS; ERYTHEMA; FEMALE; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; LETTER; NEUTROPHIL; NEUTROPHILIA; PHYSICAL EXAMINATION; PREMEDICATION; PRIORITY JOURNAL; SATELLITE CELL; SKIN BIOPSY; SPONGIOSIS; TISSUE CHARACTERIZATION; TREATMENT DURATION;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DRUG ERUPTIONS; ERYTHEMA; FEMALE; HAND DERMATOSES; HUMANS; LEG DERMATOSES; NEUTROPHILS; PACLITAXEL;

EID: 78751478172     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0956     Document Type: Letter

References (14)

1. Stanford BL, Hardwicke F. A review of clinical experience with paclitaxel extravasations. Support Care Cancer 2003; 11: 270-277.
2. Young PC, Montemarano AD, Lee N, Sau P, Weiss RB, James WD. Hypersensitivity to paclitaxel manifested as a bullous fixed drug eruption. J Am Acad Dermatol 1996; 34: 313-314.
3. Payne JY, Holmes F, Cohen PR, Gagel R, Buzdar A, Dhingra K. Paclitaxel: severe mucocutaneous toxicity in a patient with hyperbilirubinemia. South Med J 1996; 89: 542-545.
4. Weinberg JM, Egan CL, Tangoren IA, Li LJ, Laughinghouse KA, Guzzo CA. Generalized pustular dermatosis following paclitaxel therapy. Int J Dermatol 1997; 36: 559-560.
5. Kupfer I, Balguerie X, Courville P, Chinet P, Joly P. Scleroderma- like cutaneous lesions induced by paclitaxel: a case study. J Am Acad Dermatol 2003; 48: 279-281.
6. Link CJ Jr, Sarosy GA, Kohn EC, Christian MC, Davis P, Adamo DO, et al. Cutaneous manifestations of Taxol therapy. Invest New Drugs 1995; 13: 261-263.
7. De Argila D, Dominguez JD, Iglesias L. Taxol-induced acral] erythema. Dermatology 1996; 192: 377-378.
8. Bafaloukos D, Papadimitriou C, Linardou H, Aravantinos G, Papakostas P, Skarlos D, et al. Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group. Br J Cancer 2004; 91: 1639-1644.
9. Bafaloukos D, Linardou H, Aravantinos G, Papadimitriou C, Bamias A, Fountzilas G, et al. A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study. BMC Med 2010; 8: 3.
10. Rockers KM, Fielder LM. Neutrophilic dermatosis of the dorsal hands. Cutis 2009; 83: 37-39.
11. Callen JP. Neutrophilic dermatoses. Dermatol Clin 2002; 20: 409-419.
12. Defaria D, Kroumpouzos G. Rheumatoid neutrophilic dermatitis as the only presenting sign of seronegative arthritis. Acta Derm Venereol 2004; 84: 236-237.
13. Beard JS, Smith KJ, Skelton HG. Combination chemotherapy with 5-fluorouracil, folinic acid, and a-interferon producing histologic features of graft-versus-host disease. J Am Acad Dermatol 1993; 29: 325-330.
14. Yamamoto T, Ohukubo H, Nishioka K. Rheumatoid neutrophilic dermatitis. Int J Dermatol 1994; 11: 798-800.